Literature DB >> 28413637

Correlation of survivin and B-cell lymphoma 2 expression with pathological malignancy and anti-apoptotic properties of glial cell tumors.

In-Suk Bae1, Choong-Hyun Kim1, Jae-Min Kim1, Jin-Hwan Cheong1, Je-Il Ryu1, Myung-Hoon Han1.   

Abstract

Apoptosis, whose mechanism remains unclear, is regulated by multiple factors. B-cell lymphoma 2 (Bcl-2) is a well-known anti-apoptotic mediator. Survivin is also a recently recognized novel family inhibitor of apoptosis protein, which inhibits apoptosis via a pathway distinct from Bcl-2 family members. Survivin and Bcl-2 are expressed in various types of human cancer. In the present study, survivin and Bcl-2 expression were characterized in glial cell tumors, and the correlation with pathological malignancy and anti-apoptotic properties were investigated. Fifty-eight patients who had undergone surgical resection for glial cell tumors were evaluated. The pathological types of glial cell tumors were categorized according to the World Health Organization classification. Survivin and Bcl-2 expression levels were investigated by western blot analysis, and apoptosis was detected by DNA fragmentation analysis. The anti-apoptotic rate of glial cell tumors was calculated in tumor samples according to the expression of survivin and Bcl-2 or co-expression. Survivin was characterized in 60.3%, and Bcl-2 was expressed in 43.1% of glioma samples. Co-expression of survivin and Bcl-2 was observed in 25.9% of the tumor specimens. Survivin expression in astrocytic tumors was identified to be significantly associated with the pathological grade (P<0.05); however, Bcl-2 was not (P>0.05). Anti-apoptotic rate of glial cell tumors were detected in 91.4, 92.0 and 100% of patients exhibiting survivin, Bcl-2 or co-expression, respectively. However, the difference in anti-apoptotic frequency between the three groups was not identified to be statistically significant (P>0.05). The present study suggests that survivin expression is correlated with pathological grades of gliomas. In addition, the expression of survivin or Bcl-2 exerts potent anti-apoptotic properties in gliomas. Thus, survivin or Bcl-2 may serve as potential targets for inducing the apoptosis of gliomas.

Entities:  

Keywords:  B-cell lymphoma 2; apoptosis; glioma; malignancy; survivin

Year:  2017        PMID: 28413637      PMCID: PMC5374903          DOI: 10.3892/br.2017.861

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  25 in total

1.  Quantitatively determined survivin expression levels are of prognostic value in human gliomas.

Authors:  Arnab Chakravarti; Elizabeth Noll; Peter McL Black; Daniel F Finkelstein; Dianne M Finkelstein; Nicholas J Dyson; Jay S Loeffler
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

Review 2.  Apoptotic cell signaling in cancer progression and therapy.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  Integr Biol (Camb)       Date:  2011-02-22       Impact factor: 2.192

3.  Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.

Authors:  D S O'Connor; D Grossman; J Plescia; F Li; H Zhang; A Villa; S Tognin; P C Marchisio; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

4.  Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.

Authors:  Roberto Würth; Alessandra Pattarozzi; Monica Gatti; Adirano Bajetto; Alessandro Corsaro; Alessia Parodi; Rodolfo Sirito; Michela Massollo; Cecilia Marini; Gianluigi Zona; Daniela Fenoglio; Gianmario Sambuceti; Gilberto Filaci; Antonio Daga; Federica Barbieri; Tullio Florio
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

5.  Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

Authors:  H Kawasaki; D C Altieri; C D Lu; M Toyoda; T Tenjo; N Tanigawa
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

Review 6.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

7.  Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels.

Authors:  B K Kleinschmidt-DeMasters; David Heinz; Paul J McCarthy; Joanna B Bobak; Kevin O Lillehei; A Laurie W Shroyer; Kenneth R Shroyer
Journal:  Arch Pathol Lab Med       Date:  2003-07       Impact factor: 5.534

Review 8.  Recent advances in anti-survivin treatments for cancer.

Authors:  R K Kanwar; C H A Cheung; J-Y Chang; J R Kanwar
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

9.  Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients.

Authors:  Masayuki Kanamori; Tsuyoshi Higa; Yukihiko Sonoda; Shohei Murakami; Mina Dodo; Hiroshi Kitamura; Keiko Taguchi; Tatsuhiro Shibata; Mika Watanabe; Hiroyoshi Suzuki; Ichiyo Shibahara; Ryuta Saito; Yoji Yamashita; Toshihiro Kumabe; Masayuki Yamamoto; Hozumi Motohashi; Teiji Tominaga
Journal:  Neuro Oncol       Date:  2014-10-10       Impact factor: 13.029

10.  Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma.

Authors:  David Corwin; Clay Holdsworth; Russell C Rockne; Andrew D Trister; Maciej M Mrugala; Jason K Rockhill; Robert D Stewart; Mark Phillips; Kristin R Swanson
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more
  3 in total

1.  Carboxamide derivatives induce apoptosis in the U251 glioma cell line.

Authors:  Tao Yan; Junxue Zhuang; Lu He
Journal:  Oncol Lett       Date:  2019-06-04       Impact factor: 2.967

2.  Overexpression of apoptosis-related protein, survivin, in fibroblasts from patients with systemic sclerosis.

Authors:  Mohammad Bagher Mahmoudi; Ehsan Farashahi Yazd; Farhad Gharibdoost; Mohammad Hasan Sheikhha; Elham Karimizadeh; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Ir J Med Sci       Date:  2019-02-13       Impact factor: 1.568

3.  Effects of propofol on cardiac function and miR-494 expression in rats with hepatic ischemia/reperfusion injury.

Authors:  Jie Lv; Xiaohua Zou; Chao Yu; Wei Ou; Chengyi Sun
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.